Aurinia Pharmaceuticals, Inc. (AUPH)
16.57
-0.08
(-0.48%)
USD |
NASDAQ |
Oct 12, 16:00
16.57
0.00 (0.00%)
After-Hours: 18:03
Aurinia Pharmaceuticals Price : 16.57 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 16.16 | 16.97 | 16.12 | 16.65 | 849428.0 |
| Oct 08, 2026 | 15.91 | 16.30 | 15.80 | 16.22 | 831039.0 |
| Oct 07, 2026 | 15.56 | 16.16 | 15.50 | 16.01 | 682530.0 |
| Oct 06, 2026 | 15.77 | 15.82 | 15.47 | 15.69 | 699165.0 |
| Oct 05, 2026 | 15.76 | 15.80 | 15.60 | 15.72 | 802893.0 |
| Oct 02, 2026 | 16.06 | 16.06 | 15.74 | 15.83 | 813425.0 |
| Oct 01, 2026 | 16.19 | 16.24 | 15.92 | 15.95 | 934032.0 |
| Sep 30, 2026 | 16.43 | 16.44 | 16.19 | 16.20 | 913844.0 |
| Sep 29, 2026 | 16.39 | 16.48 | 16.16 | 16.42 | 734702.0 |
| Sep 28, 2026 | 16.41 | 16.62 | 16.24 | 16.52 | 626248.0 |
| Sep 25, 2026 | 16.60 | 16.78 | 16.31 | 16.44 | 740884.0 |
| Sep 24, 2026 | 16.35 | 16.66 | 16.28 | 16.60 | 809430.0 |
| Sep 23, 2026 | 16.58 | 16.89 | 16.27 | 16.40 | 787299.0 |
| Sep 22, 2026 | 16.72 | 16.80 | 16.55 | 16.67 | 885011.0 |
| Sep 21, 2026 | 16.90 | 16.92 | 16.56 | 16.61 | 668286.0 |
| Sep 18, 2026 | 16.93 | 17.03 | 16.80 | 16.90 | 1.198M |
| Sep 17, 2026 | 17.06 | 17.16 | 16.75 | 16.96 | 850194.0 |
| Sep 16, 2026 | 16.16 | 16.97 | 16.10 | 16.96 | 1.172M |
| Sep 15, 2026 | 16.35 | 16.35 | 15.98 | 16.13 | 942036.0 |
| Sep 14, 2026 | 16.03 | 16.52 | 15.93 | 16.41 | 753477.0 |
| Sep 11, 2026 | 16.28 | 16.35 | 16.06 | 16.10 | 745441.0 |
| Sep 10, 2026 | 16.12 | 16.20 | 15.90 | 16.11 | 687406.0 |
| Sep 09, 2026 | 15.97 | 16.32 | 15.85 | 16.25 | 723296.0 |
| Sep 08, 2026 | 15.98 | 16.38 | 15.93 | 16.07 | 970280.0 |
| Sep 04, 2026 | 15.97 | 16.22 | 15.93 | 16.08 | 526595.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| enGene Therapeutics, Inc. | 1.695 |
| Medicus Pharma Ltd. | 3.67 |
| Xenon Pharmaceuticals, Inc. | 35.78 |
| Psyence Biomedical Ltd. | 4.78 |
| Agenus, Inc. | 7.42 |
Price Related Metrics
| PE Ratio | 7.244 |
| PS Ratio | 7.252 |
| PEG Ratio | 0.0166 |
| Price to Book Value | 3.582 |
| Price to Free Cash Flow | 12.97 |
| Earnings Yield | 13.81% |
| Market Cap | 2.202B |
| PEGY Ratio | 0.0166 |
| Operating PE Ratio | 16.06 |
| Normalized PE Ratio | 7.244 |